[NBY] YoY Quarter Result on 30-Sep-2020 [#Q3]

Stock
[NBY] NovaBay Pharmaceuticals, Inc.
Announcement Date
12-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- 28.13%
YoY- -1,042.20%
Quarter Report
NBY's Result
NBY's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 3,255 3,826 1,840 2,170 1,615 3,142 4,091 -3.73%
PBT -1,757 -136 -2,289 -3,221 -282 -1,538 -2,447 -5.36%
Tax -51 -321 -1 1,588 -2,149 -267 281 -
NP -1,757 -5,793 -2,289 -3,221 -282 -1,538 -2,447 -5.36%
Tax Rate - - - - - - - -
Total Cost 5,012 9,619 4,129 5,391 1,897 4,680 6,538 -4.33%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin -53.98 -151.41 -124.40 -148.43 -17.46 -48.95 -59.81 -1.69%
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -13.11 -126.40 -62.42 -98.55 -14.96 -110.25 -195.62 -36.25%
EPS Diluted -13.11 -126.40 -62.42 -98.55 -18.84 -128.95 -196.00 -36.27%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.